A Glimpse of Intellia Therapeutics's Earnings Potential
A Glimpse of Intellia Therapeutics's Earnings Potential
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.Intellia Therapeutics (NASDAQ:NTLA) is gearing up to announce its quarterly earnings on Thursday, 2024-11-07. Here's a quick overview of what investors should know before the release.
Intellia Therapeutics（纳斯达克：NTLA）正准备在2024年11月7日星期四公布季度财报。在发布之前，投资者应该了解的一些重要信息如下。
Analysts are estimating that Intellia Therapeutics will report an earnings per share (EPS) of $-1.38.
分析师预计Intellia Therapeutics的每股收益（EPS）将为-1.38美元。
Investors in Intellia Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
Intellia Therapeutics的投资者正急切等待公司的公告，希望能获得超出预期的消息，并获得下一季度的积极指引。
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
值得新投资者注意的是，股票价格往往受未来预期的影响，而不仅仅是过去的业绩。
Performance in Previous Earnings
Performance in Previous Earnings
In the previous earnings release, the company missed EPS by $0.29, leading to a 4.11% drop in the share price the following trading session.
在上一次的财报发布中，该公司的EPS不及0.29美元，导致随后交易日股价下跌了4.11%。
Here's a look at Intellia Therapeutics's past performance and the resulting price change:
让我们回顾一下Intellia Therapeutics过去的表现和由此产生的价格变动：
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -1.23 | -1.38 | -1.45 | -1.50 |
| EPS Actual | -1.52 | -1.12 | -1.46 | -1.38 |
| Price Change % | -4.0% | -2.0% | -4.0% | -3.0% |
| 季度 | 2024年第二季度 | Q1 2024 | 2023年第四季度 | 2023年第三季度 |
|---|---|---|---|---|
| 每股收益预估值 | -1.23 | -1.38 | -1.45 | -1.50 |
| 每股收益实际值 | -1.52 | -1.12 | -1.46 | -1.38 |
| 价格变更% | -4.0% | -2.0% | -4.0% | -3.0% |
Stock Performance
股票表现
Shares of Intellia Therapeutics were trading at $15.43 as of November 05. Over the last 52-week period, shares are down 37.16%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
Intellia Therapeutics股票截至11月05日报价为15.43美元。在过去的52周内，股价下跌了37.16%。鉴于这些回报通常为负，长期股东可能在此财报发布前感到不满。
To track all earnings releases for Intellia Therapeutics visit their earnings calendar on our site.
要追踪Intellia Therapeutics的所有财报，请访问我们网站上的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自动内容引擎生成，并由编辑审核。
